ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Prediction of prognosis and immunotherapy response with a robust immune-related lncRNA pair signature in lung adenocarcinoma

Cao, Kui; Liu, Mingdong; Ma, Keru; Jiang, Xiangyu; Ma, Jianqun*; Zhu, Jinhong*哈尔滨医科大学
Cancer Immunology, Immunotherapy2022-6DOI: 10.1007/s00262-021-03069-1
14被引8阅读
引用收藏
分享

摘要

The tumor immune microenvironment plays essential roles in regulating inflammation, angiogenesis, immune modulation, and sensitivity to therapies. Here, we developed a powerful prognostic signature with immune-related lncRNAs (irlncRNAs) in lung adenocarcinoma (LUAD). We obtained differentially expressed irlncRNAs by intersecting the transcriptome dataset for The Cancer Genome Atlas (TCGA)-LUAD cohort and the ImmLnc database. A rank-based algorithm was applied to select top-ranking altered irlncRNA pairs for the model construction. We built a prognostic signature of 33 irlncRNA pairs comprising 40 unique irlncRNAs in the TCGA-LUAD cohort (training set). The immune signature significantly dichotomized LUAD patients into high- and low-risk groups regarding overall survival, which is likewise independently predictive of prognosis (hazard ratio = 3.580, 95% confidence interval = 2.451-5.229, P < 0.001). A nomogram with a C-index of 0.79 demonstrates the superior prognostic accuracy of the signature. The prognostic accuracy of the signature of 33 irlncRNA pairs was validated using the GSE31210 dataset (validation set) from the Gene Expression Omnibus database. Immune cell infiltration was calculated using ESTIMATE, CIBERSORT, and MCP-count methodologies. The low-risk group exhibited high immune cell infiltration, high mutation burden, high expression of CTLA4 and human leukocyte antigen genes, and low expression of mismatch repair genes, which predicted response to immunotherapy. Interestingly, pRRophetic analysis demonstrated that the high-risk group possessed reverse characteristics was sensitive to chemotherapy. The established immune signature shows marked clinical and translational potential for predicting prognosis, tumor immunogenicity, and therapeutic response in LUAD.

学科与关键词

关键词
NSCLCIrlncRNA pairPrognosisSignatureNomogram
相关
加载中…
  • Immune signature-based risk stratification and prediction of immune checkpoint inhibitor's efficacy for lung adenocarcinoma.
    Yi, Ming; Li, Anping; Zhou, Linghui; Chu, Qian; Luo, Suxia*; Wu, Kongming*Cancer Immunol Immunother, 2021, 70(6): 1705-1719.
  • Development and validation of an endoplasmic reticulum stress long non-coding RNA signature for the prognosis and immune landscape prediction of patients with lung adenocarcinoma
    Zeng, Jie; Wu, Zhenyu; Luo, Meijuan; Xu, Xie; Bai, Wenjie; Xie, Guijing; Chen, Quhai; Liang, Dengfeng; Xu, Zixun; Chen, Mindong; Xie, Jianjiang*Frontiers in Genetics, 2023, 14: 1024444.被引 1
  • Identification of Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
    Li, Na; Wang, Jiahong; Zhan, Xianquan*Frontiers in Immunology, 2021, 12: 752643.被引 19
查看全部 →

发表信息

论文状态
公开发表
期刊
Cancer Immunology, Immunotherapy
发表日期
2022-06
卷期
第 71 卷, 第 6 期
页码
1295-1311
DOI
10.1007/s00262-021-03069-1
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Haiyan Foundation of Harbin Medical University Cancer Hospital [JJZD2020-01, JJZD2018-01]; Chunhui Project Foundation of Education Department of China [2019020]; Natural Science Foundation of China [82172786]

作者

  • C

    Cao, Kui (第一作者)

    harbin med univ

  • L

    Liu, Mingdong

    harbin med univ

查看全部 6 位作者收起作者
  • M

    Ma, Keru

    harbin med univ

  • J

    Jiang, Xiangyu

    harbin med univ

  • M

    Ma, Jianqun (通讯)

    harbin med univ

  • Z

    Zhu, Jinhong (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417